MINNEAPOLIS & BOSTON--(BUSINESS WIRE)--A process improvement program significantly improved the quality of care on six of seven guideline-recommended care measures in the largest U.S. outpatient heart failure clinical study. Twenty-four month findings from IMPROVE HF, (The Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting), funded by Medtronic, Inc. (NYSE: MDT), demonstrated that clinics using the process improvement program increased adherence to ev
For more information, please visit
http://www.businesswire.com/news/home/20090914005951/en